New oral vaccine for stomach bug tested in babies
NCT ID NCT06950645
Summary
This study tested the safety and immune response of a new oral vaccine designed to protect against rotavirus, a common cause of severe diarrhea in infants and young children. The trial involved 100 healthy participants, including adults, children, and infants, who received either the vaccine or a placebo. Researchers monitored for side effects and measured the body's immune response to see if the vaccine was safe and triggered protective antibodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTAVIRUS GASTROENTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hebei Provincial Center for Disease Control and Prevention
Shijiazhuang, Hebei, 050021, China
Conditions
Explore the condition pages connected to this study.